|
SPPL3 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.88889999999909E-05 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.642800E-03 |
| Normal-vs-Stage2 |
2.396600E-01 |
| Normal-vs-Stage3 |
1.050420E-02 |
| Normal-vs-Stage4 |
1.827390E-01 |
| Stage1-vs-Stage2 |
6.359000E-01 |
| Stage1-vs-Stage3 |
3.311600E-01 |
| Stage1-vs-Stage4 |
4.362000E-01 |
| Stage2-vs-Stage3 |
2.156800E-01 |
| Stage2-vs-Stage4 |
4.066400E-01 |
| Stage3-vs-Stage4 |
8.858200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.755130E-03 |
| Normal-vs-AfricanAmerican |
3.033800E-04 |
| Normal-vs-Asian |
2.432600E-01 |
| Caucasian-vs-AfricanAmerican |
9.403600E-02 |
| Caucasian-vs-Asian |
6.652000E-01 |
| AfricanAmerican-vs-Asian |
8.785000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.442350E-03 |
| Normal-vs-Female |
4.36919999999841E-05 |
| Male-vs-Female |
6.259600E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.169510E-02 |
| Normal-vs-Extreme_Weight |
1.435220E-01 |
| Normal-vs-Obese |
1.596310E-03 |
| Normal-vs-Extreme_Obese |
6.965000E-01 |
| Normal_Weight-vs-Extreme_Weight |
2.821200E-01 |
| Normal_Weight-vs-Obese |
5.183400E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.182000E-01 |
| Extreme_Weight-vs-Obese |
6.932400E-02 |
| Extreme_Weight-vs-Extreme_Obese |
7.584800E-01 |
| Obese-vs-Extreme_Obese |
2.357800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.38750000272725E-08 |
| Normal-vs-Age(41-60Yrs) |
2.29099999999871E-05 |
| Normal-vs-Age(61-80Yrs) |
4.704100E-02 |
| Normal-vs-Age(81-100Yrs) |
5.025000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.881800E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.063800E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.115300E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.757640E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.418400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.848600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.82170000004611E-06 |
| Normal-VS-Type2 PRCC |
5.341800E-01 |
| Normal-VS-KIRP CIMP |
4.930200E-02 |
| Normal-VS-Unclassified PRCC |
8.341300E-03 |
| Type1 PRCC-VS-Type2 PRCC |
1.857480E-03 |
| Type1 PRCC-VS-KIRP CIMP |
8.887000E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
6.235600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.203600E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.501850E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
9.014800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.538000E-01 |
| Normal-vs-N1 |
1.624640E-03 |
| Normal-vs-N2 |
1.7531999996212E-07 |
| N0-vs-N1 |
4.963000E-03 |
| N0-vs-N2 |
8.042000E-03 |
| N1-vs-N2 |
4.777900E-02 |
|
|
